GLP-1 Insurance, HSA and FSA: What Actually Gets Covered, and How to Pay Pre-Tax

GLP-1s qualify. The IRS treats prescription medication as a qualified medical expense, and GLP-1s are prescription-only, so they meet the Publication 502 standard for the diagnosis, cure, mitigation, treatment or prevention of disease. Prescriptions for both type 2 diabetes and obesity meet it. What that saves you, by rough marginal rate, on a $299/month programme:

This is the document that prevents a claim denial, and it is worth getting even when nobody asks for it. Why it exists. Weight-loss expenses occupy a grey area in IRS treatment — general "weight loss for appearance" is not a qualified expense, while treatment of a diagnosed medical condition is. A Letter of Medical Necessity (LMN) from your prescriber documents which of those you are. What it should state: - Your diagnosis, with the medical code in your chart — obesity, type 2 diabetes, or an associated condition - That the medication is prescribed to treat that diagnosed condition - The expected duration of treatment - The prescriber's signature and credentials When you need one. Many plan administrators approve GLP-1 claims on the prescription alone. But for weight-management use specifically, an LMN is strongly recommended — it is the difference between a claim that processes and one that gets kicked back months later. Keep records for at least three years. HSA and FSA accounts can be audited, and the burden of substantiation is yours:

Coverage for GLP-1s divides sharply along one line: the indication. For type 2 diabetes, coverage is common and usually straightforward. For weight management, coverage is frequently excluded outright. This is a plan-design decision by your employer or insurer, not a clinical judgment about you — which is why two people with identical health and different jobs get opposite answers. This is the source of the most common confusion in this whole area: "my plan covers Ozempic but not Wegovy." Same molecule — semaglutide. Ozempic is approved for type 2 diabetes; Wegovy for weight management. Many formularies cover the first and exclude the second. Where coverage does exist, expect utilisation management:

A denial is the first stage of a process, not the end of one, and appeals succeed more often than most people expect. Read the denial letter for the specific reason. It will state one — not medically necessary, criteria not met, non-formulary, step therapy not completed. Your appeal must answer that reason. A general letter saying the medication is important will fail. Then, in order:

Most cash-pay telehealth providers accept HSA and FSA cards, because they are processing a medical expense. But the practical experience varies, and two things determine whether it goes smoothly. Card acceptance at point of sale. Some providers' payment processors are coded so an HSA/FSA debit card is accepted directly. Others are not, and you pay with a personal card and submit for reimbursement — which works, but requires you to front the money and file. Itemisation. As above, you need a receipt naming the medication. This is where all-inclusive bundled pricing can create friction. From our provider research, examples of stated HSA/FSA acceptance include Willow, which accepts HSA/FSA with no insurance required, and Found, which is built around insurance billing and reports most members paying under $30 per visit for clinical care.

Are GLP-1s HSA and FSA eligible? Yes, with a prescription. Under IRS Publication 502, qualified medical expenses include amounts paid for the diagnosis, cure, mitigation, treatment or prevention of disease. GLP-1s are prescription-only, and prescriptions for both type 2 diabetes and obesity meet the standard. Does that work even if my insurance denied coverage? Yes. These are separate systems. An insurance denial concerns reimbursement; HSA/FSA eligibility concerns whether the expense is medically qualified. A denial does not affect your ability to use the card. How much does paying pre-tax actually save? Your marginal rate — roughly 22% to 37%. On a $299/month programme that is about $790 to $1,330 a year. Do I need a Letter of Medical Necessity? Not always required, but strongly recommended for weight-management use. It documents that the medication treats a diagnosed condition rather than being a cosmetic weight-loss expense. Get it at the appointment where you receive the prescription. What records should I keep, and for how long? The prescription, the LMN, itemised receipts showing provider, medication, date and amount, and reimbursement confirmations — for at least three years, since HSA and FSA accounts can be audited. Why does my plan cover Ozempic but not Wegovy? Same molecule, different approved indication. Ozempic is approved for type 2 diabetes; Wegovy for weight management. Many formularies cover diabetes indications and exclude weight-management ones. What is prior authorisation? Your plan requiring clinical documentation to be submitted and approved before it will pay. Common additions include a higher BMI threshold than the FDA's, documented prior treatment failure, step therapy and quantity limits. My claim was denied. Is that final? No. Read the specific reason, have your prescriber request a peer-to-peer review, document the exact criteria you meet, and escalate to external review if internal appeals fail. Watch the deadline — often 180 days from the denial date. Can I use HSA or FSA for compounded semaglutide? Generally yes, as a prescription medication — but some administrators scrutinise compounded products more closely because they are not FDA-approved. Have the LMN and an itemised receipt naming the medication. What is the difference between HSA and FSA here? FSA funds are use-it-or-lose-it within the plan year but the full election is available from day one. HSA funds roll over indefinitely and are yours permanently. What if I have Medicare? Medicare Part D coverage for weight-loss indications has historically been restricted. Ask specifically about bridge programmes — Found operates one at around $50/month.